Ignite Creation Date:
2025-12-24 @ 2:02 PM
Ignite Modification Date:
2025-12-27 @ 10:02 PM
Study NCT ID:
NCT04988295
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-23
First Post:
2021-07-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-17
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-30
First Submit QC Date:
None
Study First Post Date:
2021-08-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-16
Results First Submit QC Date:
None
Results First Post Date:
2025-04-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-04-16
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED